VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000084 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
9,360
Total Value
$2,529,204.63
P&L
+inf% (+$1,877,290.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP and Chief Legal Officer | Common Stock | โ | Feb 17, 2026 | Grant/Award | 4,135 | $0.00 | $0.00 | 20,973 | Direct | โ | View Details | |
EVP and Chief Legal Officer | Common Stock | โ | Feb 17, 2026 | Tax Withholding | 1,505 | $483.75 | $728,043.75 | 19,468 | Direct | โ | View Details | |
EVP and Chief Legal Officer | Common Stock | โ | Feb 17, 2026 | Sale | 2,476 | $489.46 | $1,211,902.96 | 16,992 | Direct | โ | View Details | |
EVP and Chief Legal Officer | Common Stock | โ | Feb 18, 2026 | Sale | 1,244 | $473.68 | $589,257.92 | 15,748 | Direct | โ | View Details |